Decreased viability in neuroblastoma (Li et al., 2018, p. 2) and glioblastoma (Sun et al., 2019), and invasion capacity in breast carcinoma (Zhuang et al., 2020) cells by RRM2 inhibition were defined previously. The gene discussed is RRM2; the disease is breast carcinoma.